Year-Long Study on Gastrointestinal Effects of Tlando in American Males with Hypogonadism
Reading Time: 3 minutes Introduction Tlando, an oral testosterone replacement therapy, has been increasingly prescribed to American males suffering from low testosterone levels. While its efficacy in addressing hypogonadism is well-documented, the long-term effects on gastrointestinal health remain a subject of ongoing research. This article presents a comprehensive analysis of a year-long study focusing on the gastrointestinal impact of Tlando oral capsules in American males, offering valuable insights for healthcare providers and patients alike. Study Design and Methodology The study involved 200 American males aged 30 to 65 years, diagnosed with hypogonadism and prescribed Tlando oral capsules. Participants were monitored over a period of...


